GLP-2/T 30mg
$115.00
GLP-2/T is a dual GIP and GLP-1 receptor agonist developed to improve glucose tolerance and adiposity management. It mimics the body’s natural incretin signaling to enhance insulin sensitivity, suppress appetite, and reduce body-fat mass.
BUY 5 save 5%
BUY 10 save 10%
In stock
View test results for 30mgDescription
Mechanism of Action:
- GLP-1 receptor activation → enhances insulin secretion, slows gastric emptying, and promotes satiety.
- GIP receptor activation → supports lipid metabolism and amplifies insulin’s metabolic effects.
The dual action provides superior metabolic stability and sustained energy balance.
Research Highlights:
In phase 3 SURPASS trials, GLP-2T produced up to 22.5% mean weight loss over 72 weeks and marked reductions in HbA1C.
Improved adipokine and inflammatory profiles have been observed in pre-clinical models.
References: PMID 35701225 | Lancet Diabetes Endocrinol 2022 | Cell Metab 2023
Potential Applications (for research use):
- Obesity and insulin-resistance research
- Adipose-metabolism and GLP/GIP synergy studies
Stacking Callouts:
Often combined with MOTS-C or NAD⁺ in mitochondrial and endurance-based research.
Disclaimer:
For laboratory and research use only. Not for human consumption.
